Arkolith/Insider Trading/AMRX/Form 4

Patel Chintu

Co-CEO, DirectorAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Tax withholding(F)29K$13.30$385K1.4M
Mar 4, 2026Option exercise(M)93K——1.4M
Mar 3, 2026Option exercise(M)734K——1.6M
Mar 3, 2026Option exercise(M)60K——924K
Mar 3, 2026Tax withholding(F)17K$13.31$228K907K
Mar 3, 2026Tax withholding(F)316K$13.31$4.2M1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)93K—$0185K
Mar 3, 2026Option exercise(M)734K—$00
Mar 3, 2026Option exercise(M)60K—$0180K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015285) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML